Phase 3 trial of three thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant-eligible
Crossref DOI link: https://doi.org/10.1007/s00277-015-2537-2
Published Online: 2015-10-30
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hungria, V. T. M.
CrusoƩ, E. Q.
Maiolino, A.
Bittencourt, R.
Fantl, D.
Maciel, J. F. R.
Pessoa de Magalhaes, R. J.
Almeida, M. S. S.
Cury, P.
Hisgashi, F.
Peres, A. L.
Chiattone, C. S.
Text and Data Mining valid from 2015-10-30